ENSAYO ABIERTO DE FASE III PARA EVALUAR LA SEGURIDAD,TOLERABILIDAD E INMUNOGENIA DE LA VACUNA ANTINEUMOCOCICA CONJUGADA TRIDECAVALENTE SEGUIDA DE LA VACUNA ANTINEUMOCOCICA POLISACARIDA DE 23 SEROTIPOS EN RECEPTORES DE TRASPLANTE ALOGENICO DE CELULAS GERMI NALES HEMATOPOYETICAS DE 2 O MAS AÑOS DE EDAD.

Datos básicos

Protocolo:
6115A1-3003-WW
EUDRACT:
2009-012087-13
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:
2010
Año de finalización:
2013
ENSAYO CLÍNICO INTERNACIONAL

Objetivos del proyecto

Observaciones: Estado Comité: FINALIZADO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

WYETH RESEARCH DIVISION OF WYETH PHARMACEUTICALS

Resultados del Ensayo Clínico


[Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia].

Sanz MÁ; (...); Sociedad Española de Hematología y Oncología Pediátricas

Abstract of Published Item. 10.1016/j.medcli.2011.11.011. 2012


A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia.

Weitz I; (...); Deuson R

Article. 10.1185/03007995.2012.684046. 2012


A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.

Such E; (...); Sanz MA

Article. 10.1182/blood-2010-06-291658. 2011


A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.

Valcárcel D; (...); CETLAM Group

Article. 10.1002/cncr.26273. 2012


Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts

Valencia, Ana; (...); Sanz, Guillermo F.

Article. 10.1016/j.leukres.2010.08.012. 2011


Absence of mutations in the activation loop and juxtamembrane domains of VEGFR-1 and VEGFR-2 gene in chronic myelomonocytic leukemia (CMML).

Such E; (...); Sanz MA

Letter. 10.1016/j.leukres.2011.10.029. 2012


Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Cervera, Jose; (...); Sanz, Miguel A.

Article. 10.3324/haematol.2009.013243. 2010

  • Open Access.

Analysis of ASXL1, IDH1, IDH2, c-CBL, and WT1 Mutations in De Novo Acute Myeloid Leukaemia

Ibanez, Mariam; (...); Sanz, Miguel A.

Article. 2011


Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP).

Sanz MA; (...); Isitt JJ

Article. 10.1016/j.jval.2010.10.017. 2011


Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia.

Gaur GC; (...); Lo-Coco F

Article. 10.1007/s00277-012-1546-7. 2012


Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patients.

Luna I; (...); Sanz MA

Article. 10.1007/s00277-012-1596-x. 2012


Antifungal prophylaxis in the haematological patient: a practical approach.

Vázquez L; (...); Barberán J

Article. 2012


ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA PARAPSILOSIS AND CANDIDA ALBICANS BLOODSTREAM ISOLATES TO AMPHOTERICIN B DETERMINED BY FLOW CYTOMETRY METHODOLOGY

Cordon, Lourdes; (...); Peman, Javier

Article. 2010


BRAF V600E mutation in adult acute lymphoblastic leukemia.

Alonso CM; (...); Sanz Alonso MA

Letter. 10.3109/10428194.2012.733878. 2013


Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).

Jarque I; (...); Spanish Pethema Group

Article. 10.3109/13693786.2012.693213. 2013


Central nervous system involvement at first relapse in patients with acute myeloid leukemia.

Martínez-Cuadrón D; (...); Sanz MA

Article. 10.3324/haematol.2011.042960. 2011

  • Open Access.

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

Montesinos, Pau; (...); Sanz, Miguel A.

Article. 10.1182/blood-2010-04-277434. 2011


Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.

Grau S; (...); Sanz MA

Article. 10.1186/1471-2334-12-83. 2012

  • Open Access.

Cross-sectional validation study of patient-reported outcomes in patients with paroxysmal nocturnal haemoglobinuria.

Weitz I; (...); Hill A

Article. 10.1111/j.1445-5994.2012.02924.x. 2013


CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.

Such E; (...); de la Rubia J

Article. 10.3324/haematol.2011.042572. 2011

  • Open Access.

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

Tallman, Martin S.; (...); Sanz, Miguel A.

Article. 10.1182/blood-2010-06-288613. 2010


Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study

de la Rubia, Javier; (...); Sanz, Miguel A.

Article. 10.1016/j.transci.2010.09.018. 2010


Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia.

Fuster O; (...); Sanz MÁ

Article. 10.1007/s00277-011-1234-z. 2012


Guidelines for the Treatment of Invasive Fungal Disease by Aspergillus spp. and Other Fungi Issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

Fortun, Jesus; (...); Cuenca-Estrella, Manuel

Article. 10.1016/j.eimc.2011.01.010. 2011


Helicobacter pylori in the diagnosis, treatment and follow-up of primary immune thrombocytopenia in Spain Reply

Jarque, Isidro, Sanz, Miguel A.

Article. 10.1016/j.medcli.2012.11.002. 2013


Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Mallo, M.; (...); Sole, F.

Article. 10.1038/leu.2010.231. 2011


Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.

Rego EM; (...); Sanz MA

Article. 10.1182/blood-2012-08-449918. 2013


Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.

Blanes M; (...); de la Rubia J

Article. 10.1016/j.bbmt.2012.08.009. 2013


Long-term management of chronic immune thrombocytopenic purpura in adults.

Palau, Javier, Jarque, Isidro, Sanz, Miguel A

Article. 10.2147/IJGM.S4722. 2010


Modern Approaches to Treating Acute Promyelocytic Leukemia

Sanz, Miguel A., Lo-Coco, Francesco

Review. 10.1200/JCO.2010.32.1067. 2011


New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.

Daikeler T; (...); Rocha V

Article. 10.1182/blood-2012-07-445965. 2013


Open issues on bleeding and thrombosis in acute promyelocytic leukemia

Sanz, Miguel A., Montesinos, Pau

Article. 10.1016/S0049-3848(10)70013-X. 2010


Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.

Rojas R; (...); Torres A

Article. 10.4084/MJHID.2012.011. 2012

  • Open Access.

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.

Spyridonidis A; (...); Immunotherapy Subcommittee of Acute Leukemia Working Party

Article. 10.1038/leu.2011.351. 2012


Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis

Ammatuna, Emanuele; (...); Lo-Coco, Francesco

Article. 10.3324/haematol.2010.036657. 2011

  • Open Access.

Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia.

Gómez-Seguí I; (...); Sanz MA

Article. 10.1007/s00277-011-1331-z. 2012


Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

Barragan, Eva; (...); Sanz, Miguel A.

Article. 10.3324/haematol.2011.044933. 2011

  • Open Access.

Quantitative Expression Analysis of WT1 Main Isoforms in AML

Luna, Irene; (...); Sanz, Miguel A.

Article. 2011


Rapid screening of ASXL1, IDH1, IDH2, and c-CBL mutations in de novo acute myeloid leukemia by high-resolution melting.

Ibáñez M; (...); Sanz MA

Article. 10.1016/j.jmoldx.2012.06.006. 2012


Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient

Barberan, Jose; (...); de la Torre Cisneros, Julian

Article. 2011


Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

Michel, Marc; (...); Kreuzbauer, Georg

Article. 10.1179/102453311X13025568942005. 2011

  • Open Access.

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

Levis, Mark; (...); Smith, B. Douglas

Article. 10.1182/blood-2010-08-301796. 2011


Risk-Adapted Treatment for Low- and Intermediate-Risk Acute Promyelocytic Leukemia

Sanz, Miguel A., Montesinos, Pau

Article. 10.3816/CLML.2010.s.025. 2010


Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

Sanz, Miguel A.; (...); Lowenberg, Bob

Article. 10.1182/blood-2010-01-266007. 2010


Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.

Robak T; (...); Petersen J

Article. 10.1182/blood-2012-06-438804. 2012


Screening for IDH mutations in chronic myelomonocytic leukemia.

Ibañez M; (...); Sanz MA

Letter. 10.3109/10428194.2012.701295. 2013


Significance of increased blastic-appearing cells in bone marrow following myeloablative unrelated cord blood transplantation in adult patients.

Montesinos P; (...); Sanz GF

Article. 10.1016/j.bbmt.2011.11.008. 2012


SIGNIFICANCE OF INCREASED BONE MARROW BLASTS AFTER MYELOID ENGRAFTMENT IN ADULT PATIENTS UNDERGOING UNRELATED CORD BLOOD TRANSPLANTATION

Gascon, A.; (...); Sanz, M.

Article. 2010

  • Open Access.

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.

Sanz J; (...); Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH)

Article. 10.1038/bmt.2012.13. 2012


Susceptibility to amphotericin B and fluconazole determined by flow cytometry. Is it the same?

Cordon, L.; (...); Sanz, M.

Article. 2011

  • Open Access.

The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature.

Montesinos, Pau, Sanz, Miguel A

Article. 10.4084/MJHID.2011.059. 2011

  • Open Access.

The European LeukemiaNet: achievements and perspectives

Hehlmann, Ruediger; (...); Saussele, Susanne

Article. 10.3324/haematol.2010.032979. 2011

  • Open Access.

The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).

Rego EM; (...); Sanz MA

Article. 10.1179/102453312X13336169155376. 2012

  • Open Access.

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy

Montesinos, Pau; (...); Sanz, Miguel

Article. 10.1200/JCO.2010.29.2268. 2010


Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.

De la Serna J; (...); Vallejo C

Article. 2013


Treatment of multiple myeloma in the elderly: realities and hopes

De La Rubia, Javier, Sanz, Miguel A.

Review. 10.3109/10428194.2010.530361. 2011


Umbilical cord blood transplantation from unrelated donors in adult patients with chronic myeloid leukaemia

Sanz, Jaime, Sanz, Guillermo F.

Article. 10.1016/j.beha.2010.05.001. 2010


Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis and Study of the Impact of Hematopoietic Graft Source

Ferra, Christelle; (...); Ribera, Josep-Maria

Article. 10.1016/j.bbmt.2010.02.003. 2010


Caracterización Molecular De Las Leucemias Agudas De Novo

Autor/es: Mariam Ibañez Company

Tesis Doctoral

Director/es: MIGUEL ÁNGEL SANZ ALONSO


Estudio Clínico Y Biológico De La Leucemia Mielomonocítica Crónica

Autor/es: Esperanza Such Taboada

Tesis Doctoral

Director/es: MIGUEL ÁNGEL SANZ ALONSO


Trasplante De Sangre Cordón Umbilical De Donante No Emparentado En Adultos Con Enfermedades Hematológicas Malignas

Autor/es: Jaime Sanz Caballer

Tesis Doctoral

Director/es: MIGUEL ÁNGEL SANZ ALONSO


Campos de Estudio

Compartir